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Immune homeostasis is essential for the normal
functioning of the immune system, and its break-
down leads to fatal inflammatory diseases.We report
here the identification of a member of the tumor ne-
crosis factor-a-induced protein-8 (TNFAIP8) family,
designated TIPE2, that is required formaintaining im-
mune homeostasis. TIPE2 is preferentially expressed
in lymphoid tissues, and its deletion in mice leads to
multiorgan inflammation, splenomegaly, and prema-
ture death. TIPE2-deficient animals are hypersensi-
tive to septic shock, and TIPE2-deficient cells are
hyper-responsive to Toll-like receptor (TLR) and T
cell receptor (TCR) activation. Importantly, TIPE2
binds to caspase-8 and inhibits activating protein-1
and nuclear factor-kB activation while promoting
Fas-induced apoptosis. Inhibiting caspase-8 signifi-
cantly blocks the hyper-responsiveness of TIPE2-
deficient cells. These results establish that TIPE2 is
an essential negative regulator of TLR and TCR func-
tion, and its selective expression in the immune sys-
tem prevents hyperresponsiveness and maintains
immune homeostasis.
INTRODUCTION
The immune system is frequently bombarded by large quantities
of foreign antigens. Upon engaging these antigens through spe-
cific receptors, the immune system mounts specific responses
characterized by immune cell activation, proliferation, and in-
flammatory gene expression, all of which in turn lead to inflam-
mation. Upon removal of the antigen, the immune system returns
to its preactivation state, ready to respond to new antigens. The
strength and the duration of the immune responses must be
tightly regulated because uncontrolled inflammation can causesevere tissue injury and death of the organism. Immune homeo-
stasis is the inherent property of the immune system to maintain
a constant number of immune cells and to prevent deleterious
inflammatory responses despite frequent stimulations by anti-
gens. It ensures that any antigen-precipitated change of the
immune system is kept to the minimum so that the immune re-
sponses eliminate the antigen in question but do not lead to fatal
inflammatory diseases (Van Parijs and Abbas, 1998). The molec-
ular mechanisms through which immune homeostasis is main-
tained are not fully understood, but recent studies indicate that
at least two classes of molecules are required. The first class
includes molecules that limit the strength of immune cell activa-
tion and expansion. These include inhibitory cytokines (such as
transforming growth factor [TGF]-b and interleukin [IL]-10), neg-
ative regulators of the antigen receptor and Toll-like receptor
(TLR) signaling (such as CTLA-4, inhibitor-of-kB, Socs1, and
itch), and repressive transcription factors (such as Foxp3) (Van
Parijs and Abbas, 1998; Wahl et al., 2006). The second class
controls cell death, which includes Fas, Bim, Bax, and the cas-
pases -8 and -10 (Nagata and Suda, 1995; Van Parijs and Abbas,
1998). When these molecules are depleted from the immune
system, immune homeostasis fails and severe inflammatory dis-
eases ensue, which in turn lead to premature death of the organ-
ism (Van Parijs and Abbas, 1998). Because a large number of
genes in the mammalian genomes have not yet been character-
ized, the number and identity of additional genes required for
maintaining immune homeostasis are unknown.
Tumor necrosis factor (TNF)-a-induced protein 8 (TNFAIP8)—
also known as SCC-S2, GG2-1, and MDC-3.13—is a recently
identified apoptosis regulator (Kumar et al., 2000, 2004; Patel
et al., 1997; Yoshinaga-Hirabayashi and Yoneda, 2001; Zhang
et al., 2006). Like several other regulators/mediators of apoptosis,
TNFAIP8 contains a death effector domain (DED) and is able
to inhibit caspase-mediated apoptosis (Kumar et al., 2000).
Knocking down TNFAIP8 expression in tumor cells reduces
their tumorigenicity suggesting that it may play a role in onco-
genesis (Zhang et al., 2006). However, the physiological role
of TNFAIP8 is not clear. In an attempt to identify genes thatCell 133, 415–426, May 2, 2008 ª2008 Elsevier Inc. 415
regulate inflammation and immune homeostasis, we analyzed
the transcriptome of murine spinal cord before and after the
development of autoimmune encephalomyelitis, using a high-
throughput gene microarray technology. We identified more
than 100 genes that are highly expressed in inflamed but not
normal nervous tissue (Carmody et al., 2002). One of these
genes shares a high degree of sequence homology with
TNFAIP8, which we call TIPE2. Using knockout, knockdown,
and gain-of-function approaches, we established that TIPE2 is
a negative regulator of immune cell function, required for
preventing hyperresponsiveness and maintaining immune
homeostasis.
RESULTS
Identification of a New Member of the TNFAIP8 Family
from Inflamed Spinal Cord
To isolate new genes involved in autoimmune inflammation, we
used Affymetrix gene chips to examine gene expression profiles
of murine spinal cords before and after the development of ex-
perimental autoimmune encephalomyelitis (EAE) (Carmody
et al., 2002). This led to the identification of 141 genes that
were highly expressed in the inflamed spinal cord but totally ab-
sent in normal spinal cord (Carmody et al., 2002). One of these
genes was represented in the gene bank as the expressed se-
quence tag (EST) AI847688. By aligning this EST against the
mouse EST database in the gene bank using the BLAST se-
quence homology search program, we identified a putative
full-length cDNA, designated TIPE2 TNFAIP8-like 2, with a
predicted open reading frame encoding 184 amino acids
(Figure S1A). By aligning this sequence against the human EST
database in the gene bank using the same BLAST program,
we identified a putative TIPE2 human homolog that shares
94% amino acid sequence identity with murine TIPE2 (Fig-
ure S1A). Human TIPE2 shares approximately 53% identity and
78% similarity with TNFAIP8 (Kumar et al., 2000). Additionally,
TIPE2 contains a putative DED-like domain that shows signifi-
cant identity/similarity to other known DED sequences
(Figure S1B). The identity/similarity shared between DED of mu-
rine TIPE2 and those of the following proteins are as follows:
TNFAIP8, 50%/73%; murine cFLIP (FADD-like interleukin-1b-
converting enzyme inhibitory protein) DED I, 19%/32%; murine
cFLIP DED II, 13%/33%; murine caspase-8 DED I, 19%/40%;
and murine caspase-8 DED II, 20%/38%. The TIPE2 DED do-
main resides in its NH2-terminal region (Figure S1). Like other
DED-containing proteins, TIPE2 also possesses six putative
conserved a helices as determined by NPS Network Protein Se-
quence Analysis (Combet et al., 2000). Besides TIPE2, two addi-
tional members of the TNFAIP8 family may exist, which share
high degrees of sequence homology with TIPE2 and are desig-
nated in the gene bank as TNFAIP8L1 (TIPE1) and TNFAIP8L3
(TIPE3). Thus, the TNFAIP8 family may consist of at least four
members.
The chromosome location of TIPE2 was then determined by
aligning the murine and human TIPE2 sequences with murine
and human genome databases, respectively. A single locus
was identified for murine TIPE2 on chromosome III (3f1–3f3)
and for human TIPE2 on chromosome I (1q21.2–1q21.3).416 Cell 133, 415–426, May 2, 2008 ª2008 Elsevier Inc.Preferential Expression of TIPE2 in Lymphoid
and Inflamed Tissues
To determine the expression pattern of TIPE2, total RNA was ex-
tracted from tissues of perfused normal and EAE mice, fraction-
ated by electrophoresis, and transferred to a Hybond-N nylon
membrane. The RNA was then hybridized with the full-length
TIPE2 cDNA probe. A1.1 kb transcript was detected in the thy-
mus, spleen, lymph node, and small intestine, but not in the liver,
heart, muscle, testis, spinal cord, or brain of normal mice. By
contrast, high levels of TIPE2 mRNA were detected in the spinal
cord of mice with EAE (Figure 1A). Furthermore, a weak TIPE2
signal was also detected in the lung, skin and colon, which all
contain lymphoid tissues. Therefore, TIPE2 detected in the in-
flamed spinal cord is likely expressed by infiltrating cells of the
immune system.
To determine which cell type expresses TIPE2, we performed
northern blot and/or PCR analysis of a panel of cell preparations
(Figures 1B–1E). We found that macrophages, B, and T lympho-
cytes of various developmental stages, constitutively expressed
TIPE2 (Figures 1C and S2). One of the two T cell lines (EL-4) and
two of the macrophage cell lines (RAW 264.7 and Wehi 274.1)
expressed TIPE2. By contrast, neither NIH 3T3 fibroblasts nor
myeloma cell lines (SP2/0 and OKT3) constitutively expressed
TIPE2. However, following stimulation with TNF-a, NIH 3T3 fibro-
blasts expressed detectable levels of TIPE2 mRNA (Figure 1E).
Thus, TIPE2 is preferentially expressed by lymphoid and myeloid
cells but may be induced in other cell types by TNF-a.
Spontaneous Development of Fatal Inflammatory
Diseases in TIPE2-Deficient Mice
To elucidate the roles of TIPE2 in vivo, we generated TIPE2-de-
ficient mice by deleting both exons of the TIPE2 gene through
homologous recombination (Figure S3). The TIPE2 mRNA is
completely absent in mice homozygous for the gene mutation
(Figure S3C). Mice homozygous for the TIPE2 gene mutation de-
veloped normally and were born with the expected Mendelian ra-
tio. However, starting from approximately 2 months of age, many
TIPE2/ mice became chronically ill, characterized by body
weight loss, splenomegaly, leukocytosis, and multiorgan inflam-
mation. By the end of month 11, 50% of TIPE2/ mice died of
the disease (Figure 2A). Histological examinations revealed se-
vere mononuclear cell infiltration in multiple organs including
lung (Figure 2D), liver, and intestine starting approximately 3
months after the birth. The splenic microarchitecture was also
destroyed due to the enlargement of the white pulps. Serological
testing showed high levels of inflammatory cytokines such as
IL-1, IL-6, IL-12, and TNF-a as well as the inhibitory cytokine IL-
10 in the blood of TIPE2/ but not TIPE2+/+ mice (Figure 2B).
By contrast, the total amounts of immunoglobulin (Ig) of various
isotypes remained largely unchanged in 4-month-old TIPE2/
mice with the exception of IgG2a and IgG2b, which were reduced
as compared to those of control littermates (Figure S4).
This indicates that class switching of certain Ig isotypes may be
disrupted in aged TIPE2/ mice, which could be secondary to
the diseased conditions of these mice. Importantly, no increase
in seral antibodies to single- or double-stranded DNA was
detected in 4-month-old TIPE2/ mice. Splenomegaly and leu-
kocytosis were caused by an increase in the numbers of both
myeloid and lymphoid cells including CD11b+, B220+, and CD4+
cells (Figure 3). A significantly greater number of splenocytes in
TIPE2/ mice expressed the early activation marker CD69 (Fig-
ure 3D) as compared to wild-type (WT) littermates, suggesting
heightened cell activation. All mice were kept in a pathogen-
free environment. Recombination activating gene (RAG)-1-defi-
cient mice with no lymphoid cells were housed in the same envi-
ronment and did not develop spontaneous infectious diseases.
We were unable to identify any infectious agents in sick TIPE2/
mice by culture, histochemistry, and routine serological testing.
Negative Regulation of T Cell-Mediated
Immunity by TIPE2
To determine whether TIPE2 gene mutation affects immunity, we
studied humoral and cellular immune responses in TIPE2/
mice using the following three experimental systems: (1) lympho-
cytic choriomeningitis virus (LCMV) infection (Figure 4), (2) oval-
bumin (OVA) immunization with complete Freund’s adjuvant
(CFA) (Figure S5), and (3) Listeria monocytogenes infection. We
found that both CD4+ and CD8+ T cell immune responses were
significantly augmented in TIPE2/ mice as compared to their
littermate controls. This was reflected in the number of LCMV-
Figure 1. Preferential Expression of
TIPE2 in Lymphoid Tissues and Inflamed
Spinal Cord
(A–E) Northern blot and RT-PCR analyses of TIPE2
expression in selected tissues and cell prepara-
tions. In (A), RNAs were extracted from freshly har-
vested organs of either normal C57BL/6 mice (first
13 lanes) or mice with EAE (last lane). In (B), RNAs
were extracted from either untreated cells or cells
pretreated with 2 mg/ml of concanavalin (Con)-A,
or 2 mg/ml of lipopolysaccharides (LPS) for 24 hr;
OKT, the murine OKT-3 B cell line. In (C), RNAs
were extracted from the following cell types of
the C57BL/6 mice: lane 1, total thymocytes; lane
2, enriched splenic lymphocytes; lane 3, enriched
splenic macrophages. (D) shows RT-PCR analysis
of total RNA extracted from murine cell lines using
specificprimers forTIPE2andGAPDH. No template
DNA was added to the control lane. (E) shows NIH
3T3 fibroblasts were cultured with 0–25 ng/ml of
mouse TNF-a for 4 hr. TIPE2 and GAPDH expres-
sion was determined by RT-PCR.
specific CD8+ T cells in the spleen (Fig-
ures 4A and 4B), cytokines released by
LCMV- or OVA-specific cells in the cul-
ture (Figures 4C and S5), and cytokines
in the sera of mice infected with Listeria
(data not shown). In contrast to the en-
hanced cellular immunity, humoral immu-
nity in TIPE2/ mice remained largely
undisturbed. Immunization of young
TIPE2/ mice with OVA induced similar
levels of OVA-specific antibodies as
compared to their control littermates
(data not shown). Taken together, these
results indicate that cellular but not hu-
moral immunity is significantly disrupted in TIPE2/ mice. As
further discussed below, this dichotomy is likely due to the re-
ceptor-specific—but not cell-specific—functions of TIPE2.
In vitro, purified TIPE2/ T cells were hyperreactive to T cell
receptor (TCR) ligation and produced significantly higher levels
of Th17 cytokines as compared to WT controls (Figure 4D).
The production of Th1 cytokine IFN-g and Th2 cytokine IL-4
was also increased to various degrees in TIPE2/ cultures,
but no significant changes in T cell proliferation were apparent.
In addition to cytokines, CD25, CD44, and CD69 expression
was also higher in TIPE2 knockout T cells activated in
Figure 4D. Specifically, the percentages of T cells that expressed
CD25, CD44, and CD69 at the end of the culture increased from
60 ± 12, 50 ± 11 and 64 ± 11 in the wild-type group to 87 ± 1.4,
72 ± 2 and 90 ± 1.1 in the knockout group, respectively (p < 0.02)
(Figure S6). Cells used in these experiments were from 4- to
5-week-old mice that did not have detectable inflammatory
diseases or increased numbers of CD69+ activated cells.
These results indicate that TIPE2 may negatively regulate T
cell activation. To further test this theory, we utilized a retrovi-
rus-mediated gene transfer system that allows stable TIPE2
gene transfer into hematopoietic cells. We found that theCell 133, 415–426, May 2, 2008 ª2008 Elsevier Inc. 417
expression of the activation marker CD69 and cytokine IFN-g
was significantly reduced in cells overexpressing TIPE2
following stimulation with the specific antigen (Figure S7). This
Figure 2. Spontaneous Development of Fatal Inflammatory
Diseases in TIPE2-Deficient Mice
(A) The survival curves of wild-type (n = 36) and TIPE2/ littermates (n = 36)
over a period of 11 months.
(B) Increased seral cytokines in TIPE2-deficient mice. Sera were collected
from 4-month-old wild-type (n = 6) and TIPE2/ littermates (n = 6) and tested
for cytokines by ELISA. Data shown are means and SD of all mice and are
representative of three experiments.
(C) Increased spleen size in TIPE2-deficient mice. Spleens of a wild-type and
a TIPE2-deficient littermate at 4 months of age are shown.
(D) Severe interstitial lung inflammation in TIPE2-deficient mice. Lung sections
of a wild-type and a TIPE2-deficient littermate at 4 months of age are shown.
Sections were stained with hematoxylin and eosin and examined by micros-
copy with 2003 magnifications.418 Cell 133, 415–426, May 2, 2008 ª2008 Elsevier Inc.was accompanied by a small but detectable reduction in the
activation marker CD44 expression in these cells (Figure S7).
Furthermore, cell division was also reduced in cells overexpress-
ing TIPE2, indicating that TIPE2 may regulate mitosis under cer-
tain conditions. Taken together, these results indicate that TIPE2
is able to inhibit TCR-mediated T cell activation.
Hypersensitivity of TIPE2 Knockout and Knockdown
Cells to Toll-like Receptor Stimulation
To determine the potential roles of TIPE2 in innate immune re-
sponses to TLR ligands, we studied TIPE2 knockout and knock-
down cells in vitro. Upon stimulation with lipopolysaccharide
Figure 3. Characteristics of TIPE2-Deficient Mice: Wild-Type (n = 11)
and TIPE2-Deficient Littermates (n = 11)Were Sacrificed at 4Months
of Age and Tested for the Following Parameters
(A) Body and spleen weights.
(B) Blood leukocyte counts and splenocyte counts.
(C) B220+, CD4+, and CD11b+ splenocyte counts by flow cytometry following
staining cells with respective antibodies.
(D) Percentages of CD69+ splenocytes in B220+ and B220 subpopulations.
Data shown are means and SD and are representative of two experiments.
(LPS), bone marrow-derived TIPE2/ macrophages produced
significantly more IL-6 and IL-12 than wild-type cells, with rela-
tively normal amounts of TNF-a (Figure 5A). Similarly, knocking
down TIPE2 expression in the RAW 264.7 macrophages signifi-
cantly increased the levels of IL-6 protein (Figure 5C) and mRNA
(Figure 5D). The effect of TIPE2 knockdown is not limited to LPS
because responses to three additional TLR ligands were also
significantly increased in the knockdown macrophages
(Figure 5E).
Furthermore, TIPE2/ splenic B cells expressed signifi-
cantly more IL-1b and TNF-a than wild-type B cells upon stim-
Figure 4. Increased T Cell Immunity of TIPE2
Knockout Mice
(A–C) Increased T cell immune responses to LCMV infec-
tion. TIPE2/ mice and their littermate controls (n = 6), 5–6
weeks of age, were injected i.p. with 106 LCMV Armstrong
and sacrificed 8 days later. Splenocytes were collected,
stained with anti-CD8 and LCMV-specific Db/gp33-tetra-
mer, and examined by flow cytometry (A) (Ochsenbein
et al., 1999). The total numbers of CD8+, Db/gp33-tetra-
mer+ (tet+) cells per spleen were presented in (B). Spleno-
cytes were also cultured with LCMV-gp33-41 peptide
(1 mM) for 48 hr, and the concentrations of IFN-g in the su-
pernatants were determined by ELISA in (C). Results are
representative of two independent experiments. (D) In-
creased reactivity of TIPE2 knockout T cells to TCR stim-
ulation. CD4+ T cells were purified from spleens of 4- to
5-week-old wild-type (n = 5) or TIPE2-deficient littermates
(n = 5), and stimulated with indicated amounts of plate-
bound anti-CD3 and 1 mg/ml of soluble anti-CD28 mAbs.
Cytokine concentrations in the culture supernatants
were determined by ELISA at 24 hr, and proliferation
was measured by 3H-thymidine incorporation (presented
as count per minute [CPM]) at 48 hr. Data shown are
means and SD and are representative of three experi-
ments. No significant differences were detected between
knockout and control groups in terms of the number and
percentage of dead cells as determined by Annexin V
staining.
ulation with LPS or CpG (cytosine guanine nu-
cleotides) (Figure S8, A and B), indicating that
the innate immune function of TIPE2/ B cells
is also augmented. By contrast, anti-IgM-in-
duced TNF-a expression was not affected by
TIPE2 deficiency (Figure S8B). Proliferation,
apoptosis, and Ig secretion of B cells treated
with anti-IgM were not significantly different
between wild-type and TIPE2/ groups
(data not shown). Thus, TIPE2 may regulate in-
nate but not adaptive B cell responses. This
may explain why humoral immunity is not sig-
nificantly disrupted in TIPE2/ mice
(Figure S4). It is to be noted that TNF-a is sig-
nificantly affected by TIPE2 deficiency in B
cells but not in macrophages treated with
TLR ligands. This indicates that TIPE2 may
regulate TNF-a expression in a cell-specific
manner. Differences between B cells and mac-
rophages in their usage of transcription factors and signaling
molecules are likely responsible for this cell-specific effect of
TIPE2 on TNF-a.
Hypersensitivity of TIPE2 Knockout Mice
to Septic Shock
If TIPE2 deficiency enhances TLR activation, will it subject
mice to septic shock? To address this question, we studied
LPS-induced sepsis in mice that were injected with a low-dose
LPS. We found that septic shock was dramatically accelerated
and exacerbated in TIPE2/mice as compared to wild-typeCell 133, 415–426, May 2, 2008 ª2008 Elsevier Inc. 419
Figure 5. Increased Reactivity of TIPE2 Knockout and Knockdown Macrophages to Toll-like Receptor Stimulation
(A) Bone marrow-derived macrophages from wild-type and TIPE2-deficient mice (n = 5) were treated with or without LPS (100 ng/ml) for 8 hr. IL-6, IL-12p40, and
TNF-a concentrations were determined by ELISA.
(B) TIPE2 mRNA levels in wild-type and TIPE2 knockdown (KD) RAW 264.7 macrophages as determined by RT-PCR. GAPDH was used as a loading control
whereas H2O was used as the background control.
(C and D) Wild-type and TIPE2 knockdown RAW 264.7 cells were treated with LPS (100 ng/ml) for the indicated times. IL-6 protein (C) and mRNA (D) levels were
determined by ELISA and real-time PCR, respectively.
(E) Wild-type and TIPE2 knockdown RAW 264.7 cells were treated with LPS (100 ng/ml), peptidoglycans (PGN) (10 mg/ml), Poly(I:C) (50 mg/ml), or CpG oligodeoxy
nucleotides (CPG) (1 mM) for 8 hr. IL-6 concentrations in the supernatants were determined by ELISA. Data shown are representative of three experiments. The p
value shown is for all TLR treated WT cultures as compared to their respective TIPE2 KD groups. No significant differences were detected between the two
groups in terms of the number and percentage of apoptotic cells as determined by Annexin V staining.controls. This was reflected by a sharp decline in the survival rate
(0% versus 91%), a significant increase in seral IL-1b, IL-6, and
IL-12p40 (Figure 6), and severe multiorgan necrosis in TIPE2/
mice (data not shown). Because mice used in these experiments
were only 5 to 6 weeks old, not suffering from the inflammatory
syndrome described above, these data indicate that TIPE2 is di-
rectly responsible for preventing septic shock.
Negative Regulation of Activating Protein (AP)-1
and Nuclear Factor (NF)-kB Pathways by TIPE2
Most cytokines affected by TIPE2 deficiency or knockdown are
targets of two major signaling pathways downstream of both
TCR and TLR, i.e., the mitogen-activated protein (MAP) kinases420 Cell 133, 415–426, May 2, 2008 ª2008 Elsevier Inc.and the NF-kB pathways. To determine whether TIPE2 regulates
these two pathways, we performed biochemical analyses of key
signaling molecules involved. We found that the c-Jun N-termi-
nal kinase (JNK), p38, and the NF-kB pathway, but not the
extracellular signal-regulated kinase (ERK) pathway, were
targets of TIPE2 action. Specifically, TIPE2 knockdown amplified
the JNK and p38 pathways at the level of AP-1 binding to DNA
(Figure S9A), c-Fos, and c-Jun nuclear translocation (Figure 7A),
as well as JNK1/2 and p38 phosphorylation (Figures 7A and 7B).
Similarly, TIPE2 knockdown enhanced NF-kB nuclear transloca-
tion (Figure S10) and inhibitor-of-kB (IkB) phosphorylation
(Figure 7A); NF-kB binding to DNA was also increased in resting
TIPE2 knockdown cells suggesting that TIPE2 may regulate the
basal levels of the NF-kB activity (Figure S9B). By contrast, little
or no difference in ERK activation was noted between wild-type
and TIPE2 knockdown cells (Figure 7A). Consistent with these
results, JNK and p38 activities were also significantly increased
in TIPE2 knockout T cells as compared to wild-type controls
(Figure S11A). In TIPE2 knockout macrophages, significant in-
creases in IkBa degradation and phosphorylation were observed
15–60 min after LPS stimulation, whereas increases in JNK and
p38 phosphorylation were noted only at 5 and 120 min after LPS
stimulation (Figure S11B). No significant differences in ERK
phosphorylation between wild-type and TIPE2 knockout macro-
phages were noted at any time points tested. Taken together,
these data indicate that TIPE2 is a negative regulator of NF-kB,
JNK, and p38 pathways.
Caspase-8 Interaction with Endogenous TIPE2
and Its Role in TIPE2 Function
Results discussed above indicate that the point of action of
TIPE2 may lie upstream of MAPK and NF-kB pathways. Because
TIPE2 has a DED-like domain and certain DED-containing
proteins—such as caspase-8—regulate NF-kB activation, we
hypothesized that TIPE2 might interact with these proteins. To
test this theory, the HA- or FLAG-tagged TIPE2, FLAG-tagged
mutant procaspase-8 (the cysteine at position 360 was replaced
by serine to abolish its apoptotic activity), and FLAG-tagged Fas-
associated death domain (FADD) were expressed in 293 cells
Figure 6. Hypersensitivity of TIPE2 Knockout
Mice to Septic Shock: Wild-Type (n = 11) and
TIPE2-Deficient Littermates (n = 10) 5–6 Weeks of
Age, Were Injected Intravenously with a Low-
Dose LPS (15 mg/kg)
(A) The survival curves.
(B) IL-1b, IL-6, IL-12p40, and TNF-a concentrations in the
sera as determined by ELISA. For the LPS-treated group,
mice were injected with LPS as in (A), and sera were
collected 48 hr later. For the untreated group, sera were
collected from age- and sex-matched naive mice (n = 6).
Data shown are means and SD and are representative of
two experiments.
following transfection with corresponding ex-
pression plasmids (Figure S12). Coimmunopre-
cipitation analyses revealed that overexpressed
TIPE2 specifically associated with overex-
pressed or endogenous caspase-8 but not
FADD. To confirm this interaction for the endog-
enous TIPE2 protein, RAW 264.7 macrophage
extracts were used to immunoprecipitate
TIPE2-binding proteins with a specific anti-
TIPE2 antibody. Upon blotting with anti-cas-
pase-8 antibody, a strong caspase-8 signal
was detected in the precipitates (Figure 7C).
This caspase-8 signal was almost completely
absent in the TIPE2 knockdown cells, confirm-
ing the specificity of the assay. By contrast,
FLIP was not detected in the immunoprecipi-
tates. Robust interactions between endogenous
TIPE2 and caspase-8 were observed in both
resting and LPS-stimulated RAW cells, with little detectable dif-
ferences. Therefore, TLR stimulation may not be required for
TIPE2 binding to caspase-8. Importantly, both FADD and cas-
pase-8 were normally recruited to the death-inducing signaling
complex (DISC) (Figure S13) in TIPE2 knockdown cells following
Fas ligation. Caspase-8 cleavage was also normal in these cells.
By contrast, TIPE2 was not recruited to the DISC (Figure S13).
Therefore, the target of TIPE2 action on the apoptotic pathway
is likely downstream of caspase-8 or the DISC.
These results establish that TIPE2 is a caspase-8-binding
protein, which may regulate caspase-8-dependent functions.
In addition to inducing apoptosis, caspase-8 is also crucial for
lymphocyte and myeloid cell activation, presumably through
regulating the NF-kB signaling pathway (Bidere et al., 2006;
Chaudhary et al., 1999; Lemmers et al., 2007; Su et al., 2005;
Takahashi et al., 2006). Blocking caspase-8 activation with
a specific caspase-8 inhibitor impeded the phosphorylation of
IkBa, but not that of ERK, JNK, or p38 (Figure S14) (data not
shown). To determine whether caspase-8 played any role in
TIPE2 functioning, we blocked caspase-8 activity in wild-type
and TIPE2 knockdown RAW 264.7 macrophages using the cas-
pase-8 inhibitor. By flow cytometry, we found that caspase-8
blockade significantly diminished the hyperresponsiveness of
TIPE2 knockdown cells (Figure 7D). Both the percentage of
IL-6-producing cells and the mean fluorescence intensity of IL-6
were reduced. Significant reduction in IL-6 levels in the cultureCell 133, 415–426, May 2, 2008 ª2008 Elsevier Inc. 421
Figure 7. Mechanisms of TIPE2 Action
(A and B) Increased AP-1 and NF-kB activation in TIPE2 knockdown cells. Wild-type and TIPE2 knockdown RAW 264.7 cells were stimulated with LPS (100 ng/ml)
for the indicated times. c-Fos and c-Jun levels in the nuclear extracts were determined by western blot, with histone H1 serving as a loading control (A, top two
panels). Total cell lysates were also blotted with antibodies to total or phosphorylated (p) IkBa, p38, ERK (A, bottom three panels), and JNK1/2 (B).
(C) TIPE2 binds to endogenous caspase-8. Total cell lysates of wild-type and TIPE2-knockdown RAW 264.7 cells were immunoprecipitated with an anti-TIPE2
rabbit polyclonal antibody or control rabbit Ig. The immunoprecipitates and cell lysates were then blotted with anti-caspase-8 (anti-casp-8), anti-TIPE2, or anti-
FLIP antibodies. The level of TIPE2 in the crude lysate was too low to be detected by immunoblot (data not shown).
(D) Caspase-8 blockade diminishes the hyperreactivity of TIPE2 knockdown cells. Wild-type and TIPE2 knockdown RAW 264.7 cells were stimulated with LPS
(100 ng/ml) for 8 hr with or without 1 mg/ml of a caspase-8 inhibitor (Calbiochem). The level of intracellular IL-6 expression was determined by flow cytometry. Data
shown are representative of two experiments.422 Cell 133, 415–426, May 2, 2008 ª2008 Elsevier Inc.
supernatants were also observed by ELISA (data not shown).
These data indicate that TIPE2 may inhibit NF-kB activation by
enzymatically active caspase-8 (Bidere et al., 2006; Su et al.,
2005). In addition to activated caspase-8, the prodomain of the
caspase-8 precursor can also mediate NF-kB activation when
overexpressed in vitro (Chaudhary et al., 2000; Hu et al., 2000).
However, we found that TIPE2 was unable to modulate NF-kB ac-
tivation induced by the caspase-8 precursor (Figure S15).
Regulation of Fas-Mediated Apoptosis
and Activation-Induced Cell Death by TIPE2
Because caspase-8 is an apoptosis initiator, we asked whether
its new binding partner, TIPE2, regulated cell death. By compar-
ing wild-type and TIPE2 knockdown or knockout cells, we found
no evidence that TIPE2 regulated cell death induced by the
following agents/conditions: staurosporine, ultraviolet (UV),
gamma irradiation, etoposide, LPS, CpG, TNF-a, serum or
cytokine deprivation, and cell culture conditions described in
previous experiments (Figures 7E and S16) (data not shown).
However, a role for TIPE2 in T cell death was detected under
two experimental conditions. The first was the activation-
induced cell death (AICD) assay in which T cells were repeatedly
stimulated with anti-CD3 antibodies. Both CD4+ and CD8+ T cell
death was reduced in the absence of TIPE2 (Figure 7F). The sec-
ond was the Fas ligand (FasL)-induced apoptosis of the T cell line
EL-4. In the absence of FasL, wild-type and TIPE2 knockdown
EL-4 cells underwent similar degrees of spontaneous apoptosis.
By contrast, FasL-induced apoptosis was significantly blocked
in TIPE2 knockdown cells (Figure 7G). Consistent with this result,
overexpressing TIPE2 in EL-4 cells significantly enhanced FasL-
induced apoptosis (Figure S17). As discussed below, because
TIPE2 is not recruited to the DISC, the reduced apoptosis in
TIPE2 knockout and knockdown cells is likely secondary to its
effect on cell activation.
DISCUSSION
Results reported here indicate that TIPE2 is an essential negative
regulator of inflammation and immune homeostasis. TIPE2-defi-
cient mice suffer from chronic inflammatory diseases, and
TIPE2-deficient T cells and macrophages produce significantly
increased levels of inflammatory cytokines. The inflammatory
disease in TIPE2-deficient mice shares many similarities with
those of mice and/or humans deficient in fas/fasl, caspase-8,
caspase-10, bim, ctla4, tgfb, il2, il10, Ikb, socs1, itch, and
foxp3 (Chun et al., 2002; Van Parijs and Abbas, 1998; Wahl
et al., 2006). This indicates that immune homeostasis is main-
tained by multiple negative regulators that could not compen-
sate for each other, because deficiency in any one of them leads
to fatal inflammatory diseases. Since 30% of genes in the mu-rine and human genomes have not yet been studied, the total
number of genes required for maintaining immune homeostasis
remains to be determined.
TIPE2 in TCR and TLR Signaling
Results reported here indicate that TIPE2 is a critical regulator of
both TCR and TLR signaling. TCR and TLR initiate immune re-
sponses by transmitting receptor-proximal signals into immune
cells through well-organized signaling complexes, or signalo-
somes, which consist of both common and receptor-specific
signaling molecules. The receptor-proximal signals culminate
in the activation of several transcription factors, which include
AP-1 and NF-kB. These transcription factors in turn activate
genes that mediate the activation, differentiation, and effector
functions of immune cells. Results reported here suggest that
TIPE2 regulates TCR and TLR signaling by targeting—at least
in part—signaling complexes that contain caspase-8.
Although best known as an apoptosis initiator down-stream of
death receptors, caspase-8 has recently been shown to play
essential roles in immune cell activation and proliferation. Cas-
pase-8 deficiency in humans and mice not only blocks death
receptor-induced apoptosis but also leads to immune deficiency
(Chun et al., 2002; Salmena and Hakem, 2005). Caspase-8-defi-
cient immune cells are defective in their responses to both TLR
and antigen receptor stimulations (Bidere et al., 2006; Chun
et al., 2002; Lemmers et al., 2007; Salmena and Hakem, 2005;
Su et al., 2005; Takahashi et al., 2006). The effect of caspase-8
on cell activation is independent from its role in apoptosis but
may require NF-kB activation mediated by the activation recep-
tor-induced signalosome (ARIS) that contains CARMA1, Bcl10,
MALT1, and IKK (inhibitor of kB kinase) (Bidere et al., 2006;
Lemmers et al., 2007; Su et al., 2005). Although the precise
mechanism(s) through which caspase-8 activates NF-kB is/are
not clear, two theories have been put forward. The first may be
called ‘‘the prodomain theory,’’ which states that the prodomain
of the caspase-8 precursor recruits other components of the
ARIS to activate IKK (Chaudhary et al., 2000; Hu et al., 2000).
This theory is supported primarily by experiments in which cas-
pase-8 is overexpressed. The second may be called ‘‘the active
caspase theory,’’ which states that the enzymatic activity of the
caspase-8 (but not the prodomain) is required for its effect on IKK
activation (Bidere et al., 2006; Su et al., 2005). Data reported here
provide additional support for the second theory and indicate
that TIPE2 may regulate the active caspase-8-dependent—but
not prodomain-dependent—NF-kB activation. Additionally, be-
cause JNK and p38 phosphorylation is also enhanced in
TIPE2/ cells but caspase-8 inhibitors block only NF-kB (not
MAP kinase activation), we further propose that TIPE2 may reg-
ulate the MAP kinase pathway through caspase-8-independent
mechanisms.(E and F) TIPE2 knockout T cells are resistant to activation-induced, but not cytokine withdrawal-induced, cell death. Splenocytes from wild-type and TIPE2
knockout mice (n = 5) were subjected to cytokine withdrawal-induced (E) or activation-induced (F) cell death as described in Experimental Procedures. The
percentage of apoptotic cells was determined by flow cytometry following staining cells with Annexin V, anti-CD4, and anti-CD8 antibodies (Song et al.,
2000). Data shown are means and SD and are representative of two experiments.
(G) TIPE2 knockdown in EL-4 T cells renders them resistant to FasL-induced apoptosis. TIPE2 mRNA levels in nonmanipulated EL-4, control RNAi (wild-type) and
TIPE2 RNAi (knockdown) treated EL-4 cells were determined by RT-PCR (top panel). Wild-type and TIPE2 knockdown EL-4 cells were either left untreated
(control), or treated with 10 ng/ml FasL for 6 hr (bottom panel). After staining with Annexin V and propidium iodide (PI), cell death was analyzed by flow cytometry.
Data shown are means and SD of the percentages of Annexin V+ PI+ cells and are representative of two experiments.Cell 133, 415–426, May 2, 2008 ª2008 Elsevier Inc. 423
While the CARMA1-MALT1-Bcl10-caspase-8-IKK signalosome
is well characterized for T cells following TCR activation (Bidere
et al., 2006; Su et al., 2005), whether a similar signaling complex
forms following TLR activation is not clear. It was reported that
caspase-8 recruitment to the IKK complex following TLR activa-
tion in B cells could only be detected at 30 min (Lemmers et al.,
2007). Whether this occurs in macrophages is unknown. To ad-
dress this issue, we performed immunoprecipitation analyses of
primary murine macrophages and RAW macrophages using anti-
bodies to caspase-8, IKKa, and IKKb. We were unable to detect
any caspase-8 signal using these antibodies 0–60 min after LPS
stimulation (data not shown). These results indicate that (1) the
IKK-caspase-8 complex in macrophages may be unstable, or (2)
IKK and caspase-8 may reside in different signalosomes in macro-
phages following TLR4 activation.
TIPE2 in Immune Cell Apoptosis and Homeostasis
It is a well-recognized paradox that certain DED-containing pro-
teins are capable of regulating both apoptosis and cell activa-
tion. These include FADD (Hua et al., 2003; Hueber et al.,
2000), FLIP (Chang et al., 2002), and caspase-8 (Su et al.,
2005). While the molecular mechanisms underlying this paradox
are not fully understood, research about these molecules has led
to the characterization of a central apoptotic pathway operating
in a variety of cell types. This pathway is called extrinsic, death
receptor-induced, or mitochondria-independent pathway of
apoptosis. Unlike the intrinsic or mitochondria-dependent path-
way that is activated primarily by ‘‘stress factors’’ that disrupt the
integrity of the outer membrane of mitochondria, the extrinsic
pathway is activated by death receptors of the TNF family (Budi-
hardjo et al., 1999). Both pathways of apoptosis are crucial for
immune homeostasis and the normal functioning of the immune
system. However, AICD of T cells, as tested in this study, relies
primarily on the extrinsic pathway in which Fas plays an essential
role (Kabelitz et al., 1993). Results reported here establish that
TIPE2 is involved in regulating both apoptosis and activation of
T lymphocytes.
In theory, TIPE2 may regulate Fas-mediated apoptosis
through two distinct mechanisms: (1) by directly modulating
the activities of caspase-8 in the DISC, and (2) by altering the
levels of death and survival factors that control the Fas apoptotic
pathway. Because TIPE2 is not recruited to DISC upon Fas liga-
tion (Figure S13), the second, but not the first, mechanism is
most likely operating in our system. In support of this, NF-kB
activation is significantly enhanced in TIPE2 knockdown cells
both under resting and activating conditions (Figures 7A, S9B,
and S10). Because NF-kB is an effective inhibitor of Fas-induced
apoptosis (Dudley et al., 1999; Rivera-Walsh et al., 2000), we
propose that the increased NF-kB activation is responsible for
the resistance of TIPE2-deficient cells to Fas-induced apoptosis.
With the exception of the DED-like domain, TIPE2 and the other
three members of its family do not share sequence homology
with other DED-containing proteins or any other known proteins.
Therefore, the TIPE2 family may represent a previously unrecog-
nized class of apoptosis regulators.
Our data indicate that TIPE2 knockout T cells do not have an
intrinsic defect in proliferation when activated in vitro with anti-
CD3 and anti-CD28 (Figure 4D). Therefore, splenomegaly and424 Cell 133, 415–426, May 2, 2008 ª2008 Elsevier Inc.leukocytosis in TIPE2/ mice are likely mediated by prolifera-
tion-independent mechanisms. These may include a resistance
of immune cells to activation-induced cell death as shown in
Figure 7 and chronic expansion of immune cells in vivo as a result
of increased production of cytokines that promote proliferation.
In summary, we have isolated a gene from inflamed nervous
tissue and discovered that it is an essential negative regulator
of both innate and adaptive immunity. Understanding the basic
biology of this new molecule should provide unusual insights




An expressed sequence tag (AI847688) was identified from a microarray anal-
ysis (Carmody et al., 2002) as one of the 141 genes preferentially expressed in
inflamed but not normal spinal cord. A putative mouse full-length sequence
was generated by aligning the EST sequence with the mouse EST database
using the BLAST program. This gave rise to a cDNA of 555 bp (GenBank
accession number AF548004). Full-length TIPE2 was then isolated from the
spinal cord of mice with EAE by RT-PCR using TIPE2-specific primers. A
human testis cDNA clone that bears a high degree of homology with mouse
TIPE2 was identified by BLAST search of the human EST database and pur-
chased directly from ATCC (GenBank accession number BG258888, clone
number 4509736). The full-length TIPE2 was then sequenced and cloned
into the expression vector pRK5 with FLAG or HA tag at the C terminus.
Northern Blot
Total RNA of cells or tissues was prepared using the Trizol reagent (GIBCOL
BRL, Carlsbad, CA), fractionated by electrophoresis, transferred to a nylon
membrane, and hybridized at 60C with 32P-labeled DNA probes specific for
TIPE2 or GAPDH.
Generation of TIPE2-Deficient Mice
A 2.2 kb and a 5.0 kb TIPE2 genomic fragments were amplified by PCR and
cloned into the Xhol/Nhe I and the Not I/SalI sites of the pOSDUPDEL vector
(a gift from Dr. X-P Zhong, Duke University), respectively. TL1 embryonic
stem cells from 129S6/SvEvTac mice were transfected with the targeting
vector and subjected to positive and negative selection using G418 and gan-
ciclovir, respectively. Two ES cell clones were identified by Southern blot,
which had a copy of the TIPE2 gene (including both exons 1 and 2) replaced
by the neomycin resistance gene cassette. The mutant ES cells were injected
into 4-day-old C57BL/6J mouse blastocysts. The resultant chimeric male
offsprings were crossed with 129S6/SvEvTac females for germline transmis-
sion. Unless indicated otherwise, all mice used in this study were of the
129S6/SvEvTac background. Age and sex matched littermates were used
as controls. Mice were housed in the University of Pennsylvania Animal Care
Facilities under pathogen-free conditions. All procedures used were preap-
proved by the Institutional Animal Care and Use Committee.
T Cell Cytokine and Proliferation Assays
Single cell suspensions of the lymph nodes and spleens were depleted of red
blood cells using a hemolysis buffer. CD4+ T cells were then purified using the
CD4 (L3T4) MicroBeads (Miltenyi Biotec) according to the manufacturer’s pro-
tocol. Cells were cultured at a density of 1 3 106 per well in U-bottom 96-well
plates in the presence of various concentrations of plate-bound anti-CD3 mAb
and 2 mg/ml soluble anti-CD28 mAb. After 48 hr, the culture supernatants were
collected and cytokine concentrations were determined by ELISA. For the pro-
liferation assay, cells were cultured at 0.53 106 per well in the presence of the
same antibodies described above, and pulsed with 3H-thymidine (1 mCi/well)
at 40 hr. Radioactivity was measured using a flat-bed beta counter (Beckman).
Activation-Induced Cell Death (AICD) and Cytokine
Withdrawal-Induced Cell Death
Splenocytes, 33 106/well, were cultured for 48 hr in complete DMEM contain-
ing 20 U/ml IL-2 and 1 mg/ml anti-CD28 mAb in 48-well plates precoated with
1 mg/ml anti-CD3 mAb. For AICD assay, live cells were purified through a Ficoll
density gradient and restimulated with plate-bound anti-CD3 mAb (10 mg/ml)
for 24 hr. For cytokine withdrawal-induced cell death assay, live cells were cul-
tured for 24 hr in complete DMEM containing no antibodies or exogenous cy-
tokines. Cells were then stained with 7-AAD, annexin V, anti-CD4, and anti-
CD8. The percentage of apoptotic cells was determined by flow cytometry.
Flow Cytometry
For cell surface markers, cells were stained with antibodies in PBS with 2%
BSA and 0.05% sodium azide for 20 min at 4C. For intracellular cytokines,
cells were treated with Cytofix/Cytoperm kit and stained with anticytokine
antibodies (BD Biosciences). After washing, cells were analyzed on a four-
color FACS Calibur (BD Biosciences). Data analysis was performed using
the CellQuest software.
TIPE2 Knockdown
TIPE2 siRNA (50-GAAGTGAAACTCAGGTCCG-30) or scrambled control siRNA
(50-AGTGAAACAGTGCAGCTGC-30) was cloned into the lentiviral vector
pLL3.7 that carries the green fluorescent protein (GFP) cDNA. Lentiviruses
were produced by cotransfecting 293 T cells with the pLL3.7 plasmids and
packaging vectors (Rubinson et al., 2003). To knock down TIPE2 expression,
RAW 264.7 or EL-4 cells were infected with recombinant lentiviruses that carry
the TIPE2 siRNA. Cells infected with the same numbers of recombinant lentivi-
ruses that carry the control siRNA serve as wild-type controls. GFP was used to
track virus-infected cells. For the RAW 264.7 line, infected cells constitute more
than 90% of the total, whereas for the EL-4 line, infected cells constitute10%
of the total. Analysis was performed on gated GFP+ cells for the EL-4 line.
Statistical Analyses
The differences in protein and mRNA levels were analyzed by Student’s t test.
The differences in survival rates were analyzed by Mann-Whitney U test.
ACCESSION NUMBERS
The GenBank accession number for the TIPE2 sequence reported in this paper
is AF548004.
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